FDA recall D-0754-2026

Apollo Care, LLC · Class II · drug

Product

SEMAGLUTIDE 5mg (1mg/mL), Glycine 25 mg (5mg/mL), 5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202.NDC 71170-712-03

Reason for recall

Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material

Distribution

Nationwide within the U.S

Key facts

Status: Ongoing
Initiation date: 2026-07-29
Report date: 2026-08-19
Voluntary/Mandated: Voluntary: Firm initiated
Location: Columbia, MO, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0754-2026